dpp-4 inhibitors and glp-1 agonists Role of in Clinical Practice GLP-1 receptor agonists or DPP-4
Description
[DOI] [PubMed] [Google Scholar] 7
Head-to-head comparison The comparison reveals something important beyond raw percentages
Cost-effectiveness is not black and white, and accumulating data from real-world use could assist decision makers in making choices about coverage in the future
For those on semaglutide, similar dietary principles apply
Prompt evaluation by an ophthalmologist can determine if NAION or another eye condition is present
Both FAP and DPP-4 exhibit dipeptidase activity, but interestingly only FAP exhibits endopeptidase activity as well
